Stockreport

Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch

Nemaura Medical, Inc.  (NMRD) 
NASDAQ:AMEX Investor Relations: nemauramedical.com/investors
PDF Loughborough, England, Aug. 07, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarB [Read more]